Blogs about: Sunitinib
Featured Blog
Study Testing Anti-Angiogenic Drug Therapy for Metastatic Renal Cancer
CORT has initiated the SWOG S0717 Study for treatment of metastatic renal cancer that has progressed after prior sunitinib (Sutent) or sorafenib (Nexavar) therapy. These treatments are standard firs… more →
Center for Oncology Research & Treatment--Dallas, TX
PROSTATE RESEARCH: Study looks at efficacy of drug for castrate-resistant patients
Jim Tucker wrote 1 month ago: JUNE 19: URO TODAY: A new study has explored the efficacy and tolerability of sunitinib, an inhibito … more →
Prostate cancer news reports: Thursday, June 18, 2009
— 1 comment
Sitemaster wrote 1 month ago: Articles addressed in this report deal with: The reactions of men to a diagnosis of prostate cancer … more →
Study Testing Anti-Angiogenic Drug Therapy for Metastatic Renal Cancer
— 1 comment
bmirtsching wrote 6 months ago: CORT has initiated the SWOG S0717 Study for treatment of metastatic renal cancer that has progressed … more →
Today's prostate cancer news: Wednesday, October 8
Sitemaster wrote 9 months ago: Other than the PCA3 report, additional news today includes: A new review on the combination of EBRT … more →
Update on Metastatic Renal Cell Carcinoma
bmirtsching wrote 10 months ago: There have been three new drugs approved by the FDA for treatment of renal cancer between 2005 and 2 … more →
Sunitinib and Sorafenib cause Erythrocytosis, Indicative of class effect?
crimsoncanary wrote 11 months ago: Researchers report that the development of reversible erythrocytosis is a common side effect followi … more →
NICE recommends against Avastin, Nexavar, Sutent and Torisel for Kidney Cancer
crimsoncanary wrote 11 months ago: The UK’s National Institute for Health and Clinical Excellence (NICE) has made a preliminary r … more →
Genentech halt Avastin/Sutent trial following cases of microangiopathic hemolytic anemia (MAHA)
crimsoncanary wrote 1 year ago: Genentech have halted its trial of Avastin in combination with Sutent following reports of several c … more →
Sunitinib shows efficacy in the treatment of Advanced Neuroendocrine Tumors
crimsoncanary wrote 1 year ago: Sunitinib has shown efficacy in a phase II study of pancreatic neuroendocrine tumor patients. … more →
Renal (Kidney) Cancer Trial at CORT: Immunotherapy and Sunitinib
— 2 comments
bmirtsching wrote 1 year ago: CORT has opened the Phase II Argos Therapeutics trial of RNA-loaded autologous dendritic cell (DC)im … more →
Sorafenib shows broader anti AML cell activity than Imatinib or Sunitinib
crimsoncanary wrote 1 year ago: In vitro analysis of multikinas inhibitors imatinib, sorafenib, and sunitinib in human AML cell line … more →
Sutent (sunitinib) approved in Japan for GIST and RCC
crimsoncanary wrote 1 year ago: Pfizer has announced that Sutent, sunitinib malate, has been approved in Japan for Gastrointestinal … more →
Immunotherapy and Sunitinib (Sutent) Investigation for Metastatic Renal Cell Carcinoma Opening at CORT
bmirtsching wrote 1 year ago: CORT has been chosen as an investigative site for a study of immunotherapy utilizing a primed autolo … more →
Sunitinib (Sutent) for Metastatic Renal (Kidney) Cancer
bmirtsching wrote 1 year ago: Recent studies of sunitinib (Sutent) in patients with metastatic renal cell carcinoma have demonstra … more →
Post-Operative (Adjuvant) Therapy for Completely Resected Renal (Kidney) Cancer
bmirtsching wrote 1 year ago: After complete surgical resection of localized renal cell carcinoma, there is no existing standard p … more →
Sunitinib (Sutent) in Metastatic Breast Cancer and Triple-Negative (ER-,PR-, and Her-2-negative) Breast Cancer
bmirtsching wrote 1 year ago: Breast cancers that do not contain growth regulator proteins for estrogen receptor (ER), progesteron … more →
Have your say. Start a blog.
See our free features →
An 
Contraption
